Development and internal validation of preoperative transition zone prostate cancer nomogram

Thomas Steuber, Felix K H Chun, Andreas Erbersdobler, Alberto Briganti, Alexander Haese, Markus Graefen, Thorsten Schlomm, Luc Valiquette, Hartwig Huland, Pierre I. Karakiewicz

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: Up to 20% of men may harbor a transition zone (TZ) prostate cancer (PCa) at radical prostatectomy (RP). TZ PCa may be associated with more favorable RP pathologic findings than peripheral zone (PZ) PCa. To identify these men, we developed a model capable of predicting the probability of TZ PCa at RP. Methods: The study cohort consisted of 945 consecutive men treated with RP, with clinical stage, prostate-specific antigen (PSA) level, and detailed biopsy and RP pathology data available. The preoperative variables were used as predictors in the multivariate logistic regression models to predict the rate of TZ PCa at RP. PCa was defined as a TZ tumor when more than 50% of the planimetrically measured tumor volume was situated within the TZ. Regression coefficients were used to develop nomograms, which were subjected to 200 bootstrap resamples to reduce overfit bias. Results: TZ PCa at the final pathologic examination was recorded in 110 patients (11.6%). After 200 bootstraps, the most parsimonious and most accurate nomogram was 77.3% accurate in predicting the probability of TZ PCa. Conclusions: This nomogram is ideally suited to identify patients with markedly elevated, nearly metastatic serum PSA levels who harbor a TZ tumor that is highly treatable by RP.

Original languageEnglish
Pages (from-to)1295-1300
Number of pages6
JournalUrology
Volume68
Issue number6
DOIs
Publication statusPublished - Dec 2006

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Development and internal validation of preoperative transition zone prostate cancer nomogram'. Together they form a unique fingerprint.

Cite this